Chronic liver disease is a leading cause of death in Australia, increasing by 60% in the last two decades. Viral hepatitis is responsible for up to 60% of these death and are predominantly managed in the community. This thesis presents a world first community screening study to identify those at greatest risk with viral hepatitis. This study demonstrated that screening with non-invasive technology is cost effective and lifesaving. The data presented here suggests that rates of severe disease in the community is greater than previous estimated and area for future intervention
It is estimated that between 90,000 to 160,000 people live with chronic hepatitis B in Australia, ye...
Objective: The objective of this study was to assess the prevalence of hepatitis C virus (HCV) in re...
Viral hepatitis affects more than 320 million people globally, leading to significant morbidity and ...
Background: Approximately 1% of Australians have chronic hepatitis B (CHB), which disproportionately...
a resolution calling for a comprehensive approach to the prevention and control of all forms of vira...
© 2018 John Wiley & Sons Ltd Aims and objectives: To investigate hepatocellular carcinoma screening ...
Background: Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C viru...
BACKGROUND: Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C viru...
Liver cirrhosis is an advanced stage of liver fibrosis causing liver failure, and may progress to he...
Liver disease is now the third most common cause of premature death in the UK, with chronic viral he...
Viral hepatitis affects more than 320 million people globally, leading to significant morbidity and ...
Viral hepatitis affects more than 320 million people globally, leading to significant morbidity and ...
Since the introduction of mandatory notification in the early 1990s, around 110,000 and 260,000 case...
Primary liver cancer (PLC) is the sixth most common cancer globally, and is the fourth leading cause...
© 2019 Dr. Thai Phuoc HongLiver cancer, the world’s second highest cause of cancer death, is reporte...
It is estimated that between 90,000 to 160,000 people live with chronic hepatitis B in Australia, ye...
Objective: The objective of this study was to assess the prevalence of hepatitis C virus (HCV) in re...
Viral hepatitis affects more than 320 million people globally, leading to significant morbidity and ...
Background: Approximately 1% of Australians have chronic hepatitis B (CHB), which disproportionately...
a resolution calling for a comprehensive approach to the prevention and control of all forms of vira...
© 2018 John Wiley & Sons Ltd Aims and objectives: To investigate hepatocellular carcinoma screening ...
Background: Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C viru...
BACKGROUND: Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C viru...
Liver cirrhosis is an advanced stage of liver fibrosis causing liver failure, and may progress to he...
Liver disease is now the third most common cause of premature death in the UK, with chronic viral he...
Viral hepatitis affects more than 320 million people globally, leading to significant morbidity and ...
Viral hepatitis affects more than 320 million people globally, leading to significant morbidity and ...
Since the introduction of mandatory notification in the early 1990s, around 110,000 and 260,000 case...
Primary liver cancer (PLC) is the sixth most common cancer globally, and is the fourth leading cause...
© 2019 Dr. Thai Phuoc HongLiver cancer, the world’s second highest cause of cancer death, is reporte...
It is estimated that between 90,000 to 160,000 people live with chronic hepatitis B in Australia, ye...
Objective: The objective of this study was to assess the prevalence of hepatitis C virus (HCV) in re...
Viral hepatitis affects more than 320 million people globally, leading to significant morbidity and ...